Verona Pharma Email Format
Biotechnology ResearchEngland, United Kingdom51-200 Employees
Verona Pharma operates as a biopharmaceutical company focused on developing and commercializing therapies for chronic respiratory diseases with significant unmet medical needs. Its leadership team has a proven track record in discovering, developing, and commercializing respiratory treatments. The company sits in the biotechnology research sector and is based in London, England, with additional offices in Raleigh and Savannah in the United States. It is publicly traded on the Nasdaq Global Market under the ticker VRNA. In July 2025, Verona Pharma was acquired by Merck Sharp & Dohme Corp.